Galapagos NV.. (GLPG) News Headlines

▮ More

Date

Headline

12/15/2020 11:04:15 PM Gilead Says Not To Pursue FDA Approval Of Filgotinib For Rheumatoid Arthritis Treatment

10/21/2020 6:23:08 AM Pre-market Movers In Healthcare Sector: ASTC, SELB, XERS, ADTX, ITRM...

10/16/2020 6:27:40 AM Pre-market Movers In Healthcare Sector: RWLK, ETTX, AMRN, CEMI...

10/16/2020 2:37:24 AM SNY/TBIO Move COVID-19 Vaccine Into Clinic, AVXL's PDD Study Promising, EIGR On Watch

10/13/2020 1:47:12 AM ATXI Plunges On Thumbs-down, VYGR's Huntington's Disease Trial On Hold, Deal Or No Deal For SURF?

10/12/2020 9:44:33 AM Gilead: Phase 2b/3 Trial Shows Efficacy Of Filgotinib - Quick Facts

10/12/2020 9:19:35 AM Gilead:Phase 2b/3 Trial Shows Efficacy Of Filgotinib For Maintenance Of Remission In Moderately And Severely Active UC

9/25/2020 1:04:00 PM European Commission Grants Marketing Authorization For Jyseleca For Treatment Of Rheumatoid Arthritis

9/11/2020 6:56:10 AM Pre-market Movers In Healthcare Sector: GENE, GLPG, NVAX, QTNT, EVFM…

9/10/2020 11:19:21 PM Galapagos Says Primary Endpoint Achieved With Ziritaxestat In NOVESA Trial In Systemic Sclerosis Patients

8/20/2020 6:13:22 AM Pre-market Movers In Healthcare Sector: KZIA, TRVN, SNSS, OCGN, GLPG...

8/19/2020 10:03:24 AM Stock Alert: Galapagos Tanks 25%

8/19/2020 6:14:41 AM Pre-market Movers In Healthcare Sector: NMTR, VRNA, AXDX, GLPG...

8/19/2020 12:36:48 AM Galapagos: Gilead Sciences Receives CRL From FDA For NDA For Filgotinib

8/19/2020 12:29:27 AM ALBO Drops NASH Drug Development, FDA Says No To Filgotinib, SUPN On Watch, Vanda & ODYSSEY

8/18/2020 11:37:20 PM Gilead Gets CRL For Filgotinib For Moderately To Severely Active Rheumatoid Arthritis Treatment

7/27/2020 4:39:15 AM Biotech Stocks Facing FDA Decision In August 2020

7/24/2020 8:23:15 AM Gilead: CHMP Adopts Positive Opinion For Jyseleca In Treatment Of Rheumatoid Arthritis

7/24/2020 8:12:41 AM Gilead And Galapagos Announce Positive European CHMP Opinion For Jyseleca For Moderate To Severe Rheumatoid Arthritis

6/4/2020 1:33:46 AM Gilead Sciences : Filgotinib Shows Sustained Efficacy In Studies On Rheumatoid Arthritis

Latest Headlines

Galapagos Nv.. (GLPG)